BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D. Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids. Addict Biol 2020;25:e12823. [PMID: 31441201 DOI: 10.1111/adb.12823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Meinhardt MW, Giannone F, Hirth N, Bartsch D, Spampinato SM, Kelsch W, Spanagel R, Sommer WH, Hansson AC. Disrupted circadian expression of beta-arrestin 2 affects reward-related µ-opioid receptor function in alcohol dependence. J Neurochem 2021. [PMID: 34919270 DOI: 10.1111/jnc.15559] [Reference Citation Analysis]
2 Karavidha KK, Burmeister M, Greenwald MK. β-Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use. Am J Addict 2021;30:351-7. [PMID: 33783060 DOI: 10.1111/ajad.13150] [Reference Citation Analysis]
3 Gong S, Fayette N, Heinsbroek JA, Ford CP. Cocaine shifts dopamine D2 receptor sensitivity to gate conditioned behaviors. Neuron 2021;109:3421-3435.e5. [PMID: 34506723 DOI: 10.1016/j.neuron.2021.08.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Becker JAJ, Pellissier LP, Corde Y, Laboute T, Léauté A, Gandía J, Le Merrer J. Facilitating mGluR4 activity reverses the long-term deleterious consequences of chronic morphine exposure in male mice. Neuropsychopharmacology 2021;46:1373-85. [PMID: 33349673 DOI: 10.1038/s41386-020-00927-x] [Reference Citation Analysis]
5 Mann A, Keen AC, Mark H, Dasgupta P, Javitch JA, Canals M, Schulz S, Robert Lane J. New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling. Sci Rep 2021;11:8288. [PMID: 33859231 DOI: 10.1038/s41598-021-87417-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Botz-Zapp CA, Foster SL, Pulley DM, Hempel B, Bi GH, Xi ZX, Newman AH, Weinshenker D, Manvich DF. Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice. Behav Brain Res 2021;415:113506. [PMID: 34352292 DOI: 10.1016/j.bbr.2021.113506] [Reference Citation Analysis]